<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04373226</url>
  </required_header>
  <id_info>
    <org_study_id>2020-A00102-37</org_study_id>
    <nct_id>NCT04373226</nct_id>
  </id_info>
  <brief_title>Arithmetic Abilities in Children With 22q11.2DS</brief_title>
  <acronym>ARITH22</acronym>
  <official_title>Study of Arithmetic Abilities of Children With 22q11.2 Deletion Syndrome Aged From 4 to 11 Years Old</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hôpital le Vinatier</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hôpital le Vinatier</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study ARITH22 will investigate the role of visuo-spatial attention on arithmetic
      abilities of children with 22q11.2 deletion syndrome.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Children with 22q11.2 deletion syndrome often have arithmetic learning disability because of
      magnitude representation impairment. Previous works suggested that magnitude representation
      impairment could be a result of endogenous visuo-spatial attention dysfunction in 22q11.2DS.
      Nevertheless this relationship is still poor explored. The influence of visuo-spatial
      abilities on arithmetic achievement could also be modulated by developmental age. The study
      ARITH22 will test these hypotheses thanks to magnitude comparisons tasks, in children with
      22q11.2 deletion syndrome and matched children without developmental disease.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">July 2020</start_date>
  <completion_date type="Anticipated">October 20, 2023</completion_date>
  <primary_completion_date type="Anticipated">July 20, 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Monocentric study with two parallel groups</intervention_model_description>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Percentage of impaired scaled score</measure>
    <time_frame>single day</time_frame>
    <description>percentage of impaired scaled score at ZAREKI-R</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Percentage of correct responses</measure>
    <time_frame>single day</time_frame>
    <description>percentage of correct responses in magnitude comparisons tasks</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mean reaction time</measure>
    <time_frame>single day</time_frame>
    <description>mean reaction time in magnitude comparison tasks</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">120</enrollment>
  <condition>22q11.2 Deletion Syndrome</condition>
  <arm_group>
    <arm_group_label>22q11.2DS</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Children aged from 4 to 11 years old with 22q11.2 deletion syndrome</description>
  </arm_group>
  <arm_group>
    <arm_group_label>NON22q11.2DS</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Children aged from 4 to 11 years old without developmental disease</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Magnitude comparison tasks and neuropsychological testing</intervention_name>
    <description>neuropsychological testing (ZAREKI-R) and magnitude comparison tasks with stimuli of different types (visual, visuo-spatial)</description>
    <arm_group_label>22q11.2DS</arm_group_label>
    <arm_group_label>NON22q11.2DS</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Diagnosis of 22q11.2 deletion syndrome or no developmental disease

          -  Aged from 4 to 11 years old

          -  French language

        Exclusion Criteria:

          -  Diagnosis of intellectual deficiency according to DSM 5 criteria

          -  Drug prescribed for somatic condition that could influence cerebral functioning
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>4 Years</minimum_age>
    <maximum_age>11 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Caroline DEMILY, MD PH</last_name>
    <role>Principal Investigator</role>
    <affiliation>Centre Hospitalier Le Vinatier</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Caroline DEMILY, MD PH</last_name>
    <phone>0450915163</phone>
    <phone_ext>+33</phone_ext>
    <email>caroline.demily@ch-le-vinatier.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Emilie FAVRE, MD</last_name>
    <phone>0450915163</phone>
    <phone_ext>+33</phone_ext>
    <email>emilie.favre@ch-le-vinatier.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Hopital Vinatier</name>
      <address>
        <city>Lyon</city>
        <state>Rhone Alpes</state>
        <zip>69678</zip>
        <country>France</country>
      </address>
    </facility>
    <contact>
      <last_name>DEMILY MD CAROLINE, PH</last_name>
      <phone>0033437915163</phone>
      <email>caroline.demily@ch-le-vinatier.fr</email>
    </contact>
    <contact_backup>
      <last_name>VIAL VERONIQUE</last_name>
      <phone>0033437915531</phone>
      <email>veronique.vial@ch-le-vinatier.fr</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>May 2020</verification_date>
  <study_first_submitted>April 30, 2020</study_first_submitted>
  <study_first_submitted_qc>April 30, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">May 4, 2020</study_first_posted>
  <last_update_submitted>June 26, 2020</last_update_submitted>
  <last_update_submitted_qc>June 26, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">June 29, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>22q11.2 deletion syndrome</keyword>
  <keyword>arithmetic</keyword>
  <keyword>magnitude representation</keyword>
  <keyword>children</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>DiGeorge Syndrome</mesh_term>
    <mesh_term>Craniosynostoses</mesh_term>
    <mesh_term>Marfan Syndrome</mesh_term>
    <mesh_term>Arachnodactyly</mesh_term>
    <mesh_term>Syndrome</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

